Skip to main content

Effect of Cold Atmospheric Plasma on Wound Healing in a Standardized Wound Model-A Prospective, Monocentric, Self-Controlled Clinical Trial

In brief

Cold plasma sped healing in split-skin graft donor wounds

In 33 patients, wound halves treated with cold atmospheric plasma healed faster than untreated halves, with smaller remaining wound areas on days 14, 21 and 28. Treatment was well tolerated, but did not improve infection signs, microbiology or scar quality; the size of the healing benefit and best treatment protocol remain unclear.

Journal
International wound journal (Q1)
Published
1 November 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Benjamin Geber, Kristina Landscheidt, Ole Goertz
PMID
43004763
DOI
10.1111/iwj.71111

Why clinicians should know about it

Abstract

Cold atmospheric plasma (CAP) has demonstrated antimicrobial and tissue-stimulatory effects and represents a promising supportive treatment modality in wound care. However, clinical evidence remains limited, particularly regarding acute and aseptic wounds and the quantification of wound-healing acceleration. In this randomized intraindividual split-wound study, patients (n = 33) with split-thickness skin graft (STSG) donor site wounds received postoperative CAP treatment on one wound half, while the other half served as control. CAP was applied according to a standardized treatment protocol for 2 min each on postoperative days 3, 5 and 7. Re-epithelialization was quantified longitudinally by image analysis. The primary endpoint was wound-healing rate from postoperative day 3 to day 14, assessed using a linear mixed-effects model. An accelerated wound healing following CAP (p = 0.017) could be shown. Furthermore, treated wound halves exhibited significantly smaller residual wound areas at postoperative days 14, 21 and 28. No significant differences were observed in microbiological outcomes, clinical wound healing score, signs of infection or scar quality. The treatment was well tolerated, and no severe adverse events were reported. CAP therapy accelerated re-epithelialization in STSG donor site wounds and may represent a promising adjunctive treatment option. Further studies are warranted to define optimal treatment protocols and clinical indications for its effective and rational use.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.